vs
GLAUKOS Corp（GKOS）与DORIAN LPG LTD.（LPG）财务数据对比。点击上方公司名可切换其他公司
GLAUKOS Corp的季度营收约是DORIAN LPG LTD.的1.2倍（$143.1M vs $120.0M），DORIAN LPG LTD.净利率更高（39.3% vs -93.4%，领先132.7%），DORIAN LPG LTD.同比增速更快（48.7% vs 35.7%），过去两年GLAUKOS Corp的营收复合增速更高（29.3% vs -7.9%）
Glaukos Corp是一家专注于眼科领域的医疗科技企业，开发并商业化用于治疗青光眼、角膜疾病等眼部病症的微创手术器械、处方药物及消费级产品，主要市场覆盖北美、欧洲及亚太地区，为全球医院、眼科诊所及患者提供服务。
Dorian LPG Ltd.是一家专注于液化石油气海运业务的国际领先航运企业，拥有并运营现代化大型液化气运输船队，为能源、石化行业客户提供运输服务，航线覆盖北美、亚洲、欧洲等核心市场。
GKOS vs LPG — 直观对比
营收规模更大
GKOS
是对方的1.2倍
$120.0M
营收增速更快
LPG
高出13.1%
35.7%
净利率更高
LPG
高出132.7%
-93.4%
两年增速更快
GKOS
近两年复合增速
-7.9%
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $143.1M | $120.0M |
| 净利润 | $-133.7M | $47.2M |
| 毛利率 | -1.1% | — |
| 营业利润率 | -97.7% | 42.8% |
| 净利率 | -93.4% | 39.3% |
| 营收同比 | 35.7% | 48.7% |
| 净利润同比 | -298.0% | 120.9% |
| 每股收益（稀释后） | $-2.34 | $1.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收GKOSLPG
| Q4 25 | $143.1M | $120.0M | ||
| Q3 25 | $133.5M | $124.1M | ||
| Q2 25 | $124.1M | $84.2M | ||
| Q1 25 | $106.7M | $75.9M | ||
| Q4 24 | $105.5M | $80.7M | ||
| Q3 24 | $96.7M | $82.4M | ||
| Q2 24 | $95.7M | $114.4M | ||
| Q1 24 | $85.6M | $141.4M |
净利润GKOSLPG
| Q4 25 | $-133.7M | $47.2M | ||
| Q3 25 | $-16.2M | $55.4M | ||
| Q2 25 | $-19.7M | $10.1M | ||
| Q1 25 | $-18.1M | $8.1M | ||
| Q4 24 | $-33.6M | $21.4M | ||
| Q3 24 | $-21.4M | $9.4M | ||
| Q2 24 | $-50.5M | $51.3M | ||
| Q1 24 | $-40.8M | $79.2M |
毛利率GKOSLPG
| Q4 25 | -1.1% | — | ||
| Q3 25 | 78.4% | — | ||
| Q2 25 | 78.3% | — | ||
| Q1 25 | 77.2% | — | ||
| Q4 24 | 72.9% | — | ||
| Q3 24 | 76.6% | — | ||
| Q2 24 | 76.4% | — | ||
| Q1 24 | 76.3% | — |
营业利润率GKOSLPG
| Q4 25 | -97.7% | 42.8% | ||
| Q3 25 | -12.3% | 47.8% | ||
| Q2 25 | -18.3% | 18.5% | ||
| Q1 25 | -19.4% | 19.4% | ||
| Q4 24 | -27.2% | 29.0% | ||
| Q3 24 | -25.5% | 23.2% | ||
| Q2 24 | -31.3% | 48.5% | ||
| Q1 24 | -45.6% | 58.3% |
净利率GKOSLPG
| Q4 25 | -93.4% | 39.3% | ||
| Q3 25 | -12.2% | 44.6% | ||
| Q2 25 | -15.8% | 12.0% | ||
| Q1 25 | -17.0% | 10.7% | ||
| Q4 24 | -31.8% | 26.5% | ||
| Q3 24 | -22.1% | 11.4% | ||
| Q2 24 | -52.8% | 44.9% | ||
| Q1 24 | -47.7% | 56.0% |
每股收益（稀释后）GKOSLPG
| Q4 25 | $-2.34 | $1.11 | ||
| Q3 25 | $-0.28 | $1.30 | ||
| Q2 25 | $-0.34 | $0.24 | ||
| Q1 25 | $-0.32 | $0.17 | ||
| Q4 24 | $-0.56 | $0.50 | ||
| Q3 24 | $-0.39 | $0.22 | ||
| Q2 24 | $-1.00 | $1.25 | ||
| Q1 24 | $-0.82 | $1.96 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $90.8M | $294.5M |
| 总债务越低越好 | — | $513.2M |
| 股东权益账面价值 | $656.2M | $1.1B |
| 总资产 | $893.5M | $1.8B |
| 负债/权益比越低杠杆越低 | — | 0.47× |
8季度趋势，按日历期对齐
现金及短期投资GKOSLPG
| Q4 25 | $90.8M | $294.5M | ||
| Q3 25 | $98.2M | $268.3M | ||
| Q2 25 | $100.8M | $277.9M | ||
| Q1 25 | $114.3M | $316.9M | ||
| Q4 24 | $169.6M | $314.5M | ||
| Q3 24 | $100.1M | $348.6M | ||
| Q2 24 | $68.1M | $353.3M | ||
| Q1 24 | $42.5M | $282.5M |
总债务GKOSLPG
| Q4 25 | — | $513.2M | ||
| Q3 25 | — | $526.4M | ||
| Q2 25 | — | $539.6M | ||
| Q1 25 | — | $553.3M | ||
| Q4 24 | — | $565.9M | ||
| Q3 24 | — | $579.0M | ||
| Q2 24 | — | $592.1M | ||
| Q1 24 | — | $605.1M |
股东权益GKOSLPG
| Q4 25 | $656.2M | $1.1B | ||
| Q3 25 | $769.5M | $1.1B | ||
| Q2 25 | $765.1M | $1.0B | ||
| Q1 25 | $764.0M | $1.0B | ||
| Q4 24 | $766.9M | $1.1B | ||
| Q3 24 | $668.5M | $1.1B | ||
| Q2 24 | $665.2M | $1.1B | ||
| Q1 24 | $450.7M | $1.0B |
总资产GKOSLPG
| Q4 25 | $893.5M | $1.8B | ||
| Q3 25 | $999.4M | $1.8B | ||
| Q2 25 | $987.0M | $1.7B | ||
| Q1 25 | $966.2M | $1.8B | ||
| Q4 24 | $974.8M | $1.8B | ||
| Q3 24 | $926.5M | $1.9B | ||
| Q2 24 | $919.7M | $1.9B | ||
| Q1 24 | $933.3M | $1.8B |
负债/权益比GKOSLPG
| Q4 25 | — | 0.47× | ||
| Q3 25 | — | 0.49× | ||
| Q2 25 | — | 0.52× | ||
| Q1 25 | — | 0.53× | ||
| Q4 24 | — | 0.53× | ||
| Q3 24 | — | 0.53× | ||
| Q2 24 | — | 0.53× | ||
| Q1 24 | — | 0.59× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $6.8M | $80.8M |
| 自由现金流经营现金流 - 资本支出 | $3.9M | — |
| 自由现金流率自由现金流/营收 | 2.7% | — |
| 资本支出强度资本支出/营收 | 2.0% | — |
| 现金转化率经营现金流/净利润 | — | 1.71× |
| 过去12个月自由现金流最近4个季度 | $-22.5M | — |
8季度趋势，按日历期对齐
经营现金流GKOSLPG
| Q4 25 | $6.8M | $80.8M | ||
| Q3 25 | $-10.1M | $46.4M | ||
| Q2 25 | $7.0M | $814.5K | ||
| Q1 25 | $-18.5M | $50.2M | ||
| Q4 24 | $507.0K | $24.3M | ||
| Q3 24 | $-9.6M | $57.3M | ||
| Q2 24 | $-18.4M | $41.2M | ||
| Q1 24 | $-33.9M | $154.2M |
自由现金流GKOSLPG
| Q4 25 | $3.9M | — | ||
| Q3 25 | $-11.7M | — | ||
| Q2 25 | $5.8M | — | ||
| Q1 25 | $-20.5M | — | ||
| Q4 24 | $-1.2M | — | ||
| Q3 24 | $-11.0M | — | ||
| Q2 24 | $-20.5M | — | ||
| Q1 24 | $-34.8M | — |
自由现金流率GKOSLPG
| Q4 25 | 2.7% | — | ||
| Q3 25 | -8.8% | — | ||
| Q2 25 | 4.7% | — | ||
| Q1 25 | -19.2% | — | ||
| Q4 24 | -1.2% | — | ||
| Q3 24 | -11.4% | — | ||
| Q2 24 | -21.4% | — | ||
| Q1 24 | -40.7% | — |
资本支出强度GKOSLPG
| Q4 25 | 2.0% | — | ||
| Q3 25 | 1.2% | — | ||
| Q2 25 | 0.9% | — | ||
| Q1 25 | 1.8% | — | ||
| Q4 24 | 1.6% | — | ||
| Q3 24 | 1.5% | — | ||
| Q2 24 | 2.2% | — | ||
| Q1 24 | 1.1% | — |
现金转化率GKOSLPG
| Q4 25 | — | 1.71× | ||
| Q3 25 | — | 0.84× | ||
| Q2 25 | — | 0.08× | ||
| Q1 25 | — | 6.20× | ||
| Q4 24 | — | 1.14× | ||
| Q3 24 | — | 6.08× | ||
| Q2 24 | — | 0.80× | ||
| Q1 24 | — | 1.95× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
GKOS
| Glaucoma | $86.4M | 60% |
| Other | $35.1M | 25% |
| Corneal Health | $21.6M | 15% |
LPG
暂无分部数据
